Evidence summary: creatine form, activity and outcome
| Option | What the evidence shows | Evidence grade | Key safety notes |
|---|---|---|---|
| Creatine monohydrate alongside resistance training — lean mass and strength after menopause | Supportive overall, with variable responses. Strength gains in the two-year postmenopausal trial did not differ from placebo; a lean-tissue benefit appeared in a completer analysis rather than across everyone randomised. Two-year creatine and exercise trial in postmenopausal women (2023) Creatine monohydrate — 2026 postmenopausal evidence synthesis | B | Water-related weight gain and stomach symptoms can occur. Kidney disease and medicines affecting kidney function need review. Tell the clinician interpreting kidney blood tests about use. |
| Creatine monohydrate — bone density or fracture prevention | The two-year trial did not improve the main bone-density measures at the femoral neck, hip or spine. Changes in some bone-geometry measures did not establish fracture prevention. Two-year creatine and exercise trial in postmenopausal women (2023) | D | Kidney history, medicines and digestive tolerance still matter. A fragility fracture or established osteoporosis needs clinical care; a training supplement cannot replace it. |
| Creatine hydrochloride — selected cognition findings at the higher study exposure in CONCRET-MENOPA | An early signal from a very small, eight-week, four-group trial. Small groups and multiple outcomes make a broad brain-fog claim premature. This does not establish superiority over monohydrate. CONCRET-MENOPA — eight-week creatine-formulation trial for cognition | C | Short follow-up cannot settle long-term safety. Review kidney disease, medicines and the exact preparation. The trial's tolerability cannot be assigned to every proprietary blend. |
| Creatine hydrochloride plus ethyl ester — menopausal cognition claim | No established broad clinical benefit for the exact mixture. Selected findings from another trial arm cannot be transferred to the combination, and a brain-creatine measurement does not prove better everyday thinking. CONCRET-MENOPA — eight-week creatine-formulation trial for cognition | D | Kidney history and medicine review remain relevant. A small trial cannot establish safety for people excluded from it. New or progressive cognitive symptoms need clinical review. |
Important grading note: Each grade is the final book's Decoded Press editorial appraisal of a named form, population and outcome. B means supportive evidence with meaningful limits; C uncertain, mixed or modest; D little reliable support for the stated claim. The B for monohydrate with resistance training is not a grade for bone protection, brain fog or every creatine preparation. These letters are not the linked studies' own grading systems.
What does creatine add to resistance training after menopause?
It may add to training-related lean mass and strength, but the postmenopausal findings are uneven.
Creatine helps supply energy for short, demanding muscular work. Monohydrate is the best-studied supplemental form. Broad sports evidence does not promise equal benefit in every menopausal woman or exercise program.
The book grades monohydrate alongside resistance training B. Its appraisal combines supportive overall research with limits in the postmenopausal evidence, including the long trial's mixed results.
Keep the training in the claim. Buying creatine is a different decision from choosing a suitable exercise program, getting useful instruction and reviewing nutrition. Ask what extra benefit the supplement is expected to contribute to your agreed goal.
Why does the two-year creatine trial need careful interpretation?
The strength result and the lean-tissue finding came from different analyses and should be described separately.
In the two-year trial, strength gains did not differ between creatine and placebo. A lean-tissue benefit appeared in an analysis of participants who completed the study. That is less secure than an effect demonstrated across everyone originally randomised.
A result among completers should not become a promise that everyone who starts a product will gain extra muscle. Nor should a measurement of lean tissue be treated as identical to an improvement in everyday strength or function.
Choose meaningful goals and discuss how progress will be assessed. A study can support a qualified training-related use while leaving important uncertainty about your own response.
Does creatine strengthen bones or prevent fractures?
The book grades monohydrate D for that claim and keeps it separate from any training-related muscle benefit.
The two-year postmenopausal trial did not improve its main bone-density measures at the femoral neck, hip or spine. Some measures of bone geometry changed, but the trial did not establish fracture prevention.
Bone density, bone geometry and fractures are different outcomes. An improvement in one measurement cannot establish fewer broken bones.
Keep a possible reason to use creatine for training separate from osteoporosis care. Low bone density or a fragility fracture needs a clinical review and a plan based on the relevant risk and treatment evidence.
Can creatine help menopausal brain fog?
The book treats the cognition findings as preliminary and specific to the formulations and study arms tested.
CONCRET-MENOPA was a very small, eight-week, four-group study. Selected findings at the higher hydrochloride study exposure were interesting, but small groups and multiple outcomes limit confidence in a broad everyday brain-fog benefit. The book grades that specific finding C.
The hydrochloride-plus-ethyl-ester combination receives D for its cognitive claim. It cannot inherit selected findings from a different arm, and a brain-creatine measurement does not itself show that everyday thinking improved.
These findings do not establish that hydrochloride is superior to monohydrate. New or progressive problems with thinking deserve clinical review rather than repeated substitutions of one supplement for another.
Is a premium creatine form better than monohydrate?
A different chemical form or an ‘enhanced’ label needs evidence of a relevant clinical advantage.
Monohydrate is the best-studied supplemental form described in the book. Paying more for a different preparation is not an evidence-based upgrade by default.
Ask whether the study tested the actual form or finished mixture being sold, in a relevant population, for the outcome you want. A muscle finding cannot establish better cognition, and one cognition-study arm cannot establish another mixture's benefit.
Product cost belongs alongside expected benefit, tolerance and the rest of your care. A more elaborate label cannot resolve uncertainty in the evidence.
Will creatine make my weight go up?
Water-related weight gain can occur, so a scale change needs context.
The book lists water-related weight gain among creatine's possible effects. Weight, fat, lean tissue and strength are different measures; a larger scale number should not automatically be treated as failure.
Discuss what you are trying to improve and how you will assess it. If your main goal is strength or daily function, the scale alone gives an incomplete picture.
Stomach symptoms can also occur. Tell your care team about new or troublesome effects, and review whether the supplement is contributing enough value to stay in the plan.
What should I check before using creatine?
Review kidney history, medicines, the exact preparation, nutrition and the reason for use.
Kidney disease or medicines that affect kidney function require clinical review. Tell the clinician interpreting kidney blood tests that you use creatine; that context can matter to interpretation.
Review stomach tolerance and all added ingredients. A small trial's reassuring tolerability cannot show long-term safety or suitability for people who were excluded from it.
Creatine, protein and other powders have different jobs. Keep suitable food intake, training and medical care in the plan. A supplement should earn its place by addressing a defined need.
A trial's amount or a proprietary product's claim is not a personal dose recommendation. A qualified clinician or pharmacist can help review the product and its fit with your history and goals.
Related questions
What to ask at your appointment
- Which goal are we addressing: strength, lean mass, daily function, bone health or thinking?
- What evidence supports this exact creatine form for that goal after menopause?
- What might it add to a suitable resistance-training and nutrition plan?
- Does my kidney history or any medicine change whether it is suitable?
- Should the clinician interpreting my kidney blood tests know about creatine use?
- How should we interpret a change in scale weight or stomach symptoms?
- Do my bone-health or cognitive concerns need separate assessment?
- What would count as worthwhile benefit, and when should we review the cost and effects?
Frequently asked questions
Is creatine useful after menopause?
Creatine monohydrate alongside resistance training receives B in the book for possible additional lean mass and strength, with uneven postmenopausal results. Bone-density and cognition claims have separate grades. The form, goal, training, nutrition and personal safety assessment matter.
Does creatine guarantee extra muscle or strength?
No. Responses vary. In the two-year postmenopausal trial, strength gains did not differ from placebo and a lean-tissue benefit appeared in a completer analysis. The book's B grade supports a qualified use alongside resistance training without guaranteeing an extra benefit for everyone.
Can creatine prevent osteoporosis or fractures?
The book gives monohydrate D for bone density or fracture prevention. The long trial did not improve the main bone-density measures, and bone-geometry changes did not establish fewer fractures. Keep a training-related use separate from clinical osteoporosis care.
Does creatine help menopause brain fog?
A very small hydrochloride trial had selected early cognition findings, graded C in the book. The hydrochloride-plus-ethyl-ester combination receives D for its broader cognition claim. These findings do not establish a general brain-fog treatment or hydrochloride's superiority to monohydrate.
Which creatine form is best studied?
The book identifies creatine monohydrate as the best-studied supplemental form. A premium preparation needs evidence for its actual form and intended outcome. Muscle evidence cannot automatically be assigned to brain fog, bone density or another mixture.
Does creatine cause weight gain?
Water-related weight gain can occur. The scale does not separately measure fat, lean tissue, strength or function, so a change needs context. Review your goals and any troublesome stomach or other symptoms with your care team.
Can I use creatine if I have kidney disease?
Kidney disease or medicines affecting kidney function require clinical review before use. Tell the clinician interpreting kidney blood tests about creatine. Trial tolerability cannot establish suitability for every person or preparation.
Sources
Adapted from Menopause Decoded, First Edition (2026), chapter 29, with measurement context from chapter 9. The four formulation- and outcome-specific grades follow the final ISBN'd book. Its targeted source checks extend through 18 September 2026; this guide's review date records the adaptation, not a new systematic review. Named trial formulations identify what was studied, not endorsement of a retail product. A qualified clinician or pharmacist should review the exact preparation and current safety information.
This guide provides general education, not a personal supplement dose, exercise prescription or treatment plan. Discuss supplement decisions, bone-health concerns and new or progressive cognitive symptoms with a qualified healthcare professional who knows your history. Read the full Medical Disclaimer.